Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (181-190 of 685) with videos related to

Pageof 69
Sort By:
The Breast Journal|March 20, 2015
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation CarriersSoley Bayraktar, Michelle Jackson, Angelica M Gutierrez-Barrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancerAna M Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, et al.
Annals of Surgery|September 5, 2009
Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patientsKelly K Hunt, Min Yi, Elizabeth A Mittendorf, et al.
Diseases of the Colon and Rectum|February 8, 2019
Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision MedicineY Nancy You, Ester Borras, Kyle Chang, et al.
Oncotarget|October 10, 2014
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypesXiaoping Su, Gabriel G Malouf, Yunxin Chen, et al.
NPJ Precision Oncology|June 12, 2026
Genomic co-alterations and immune-related adverse events shape outcomes of thymic malignancies treated with immune checkpoint inhibitorsHarold Nathan Tan, Hung Le, Khaoula Ben Haj Frej, et al.
Targeted Oncology|September 11, 2019
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced CancerSung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, et al.
The Breast Journal|December 13, 2012
Genotype in BRCA-associated breast cancersFunda Meric-Bernstam, Angelica M Gutierrez-Barrera, Jennifer Litton, et al.
Annals of Surgical Oncology|July 10, 2015
A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular CancerIsabelle Bedrosian, Yan Xing, Shereen Abdel Rahman, et al.
Cancer|February 27, 2008
Prognostic significance of HER-2 status in women with inflammatory breast cancerShaheenah Dawood, Kristine Broglio, Yun Gong, et al.
Pageof 69

Showing results (181-190 of 685) with videos related to

Sort By:
Pageof 69
The Breast Journal|March 20, 2015
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation CarriersSoley Bayraktar, Michelle Jackson, Angelica M Gutierrez-Barrera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancerAna M Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, et al.
Annals of Surgery|September 5, 2009
Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patientsKelly K Hunt, Min Yi, Elizabeth A Mittendorf, et al.
Diseases of the Colon and Rectum|February 8, 2019
Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision MedicineY Nancy You, Ester Borras, Kyle Chang, et al.
Oncotarget|October 10, 2014
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypesXiaoping Su, Gabriel G Malouf, Yunxin Chen, et al.
NPJ Precision Oncology|June 12, 2026
Genomic co-alterations and immune-related adverse events shape outcomes of thymic malignancies treated with immune checkpoint inhibitorsHarold Nathan Tan, Hung Le, Khaoula Ben Haj Frej, et al.
Targeted Oncology|September 11, 2019
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced CancerSung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, et al.
The Breast Journal|December 13, 2012
Genotype in BRCA-associated breast cancersFunda Meric-Bernstam, Angelica M Gutierrez-Barrera, Jennifer Litton, et al.
Annals of Surgical Oncology|July 10, 2015
A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular CancerIsabelle Bedrosian, Yan Xing, Shereen Abdel Rahman, et al.
Cancer|February 27, 2008
Prognostic significance of HER-2 status in women with inflammatory breast cancerShaheenah Dawood, Kristine Broglio, Yun Gong, et al.
Pageof 69